Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 1,018 | 1,877 | 860 | 1,096 | 3,585 |
| Gross Profit | 1,018 | 1,877 | 860 | 1,096 | 3,585 |
| Operating Expenses | 30,399 | 30,636 | 33,759 | 25,528 | 26,680 |
| Operating Income | -29,381 | -28,759 | -32,899 | -24,432 | -23,095 |
| Interest Expense | 888 | 880 | 845 | 925 | 953 |
| Other Income | 147 | 93 | 498 | 188 | 230 |
| Pre-tax Income | -30,122 | -29,546 | -33,246 | -25,169 | -23,818 |
| Net Income Continuous | -30,122 | -29,546 | -33,246 | -25,169 | -23,818 |
| Net Income | $-30,122 | $-29,546 | $-33,246 | $-25,169 | $-23,818 |
| EPS Basic Total Ops | -6.90 | -6.80 | -7.70 | -9.00 | -5.50 |
| EPS Basic Continuous Ops | -6.94 | -6.82 | -7.69 | -9.05 | -5.54 |
| EPS Diluted Total Ops | -6.90 | -6.80 | -7.70 | -8.30 | -5.50 |
| EPS Diluted Continuous Ops | -6.94 | -6.82 | -7.69 | -8.29 | -5.54 |
| EBITDA(a) | $-28,043 | $-27,514 | $-31,568 | $-22,976 | $-21,494 |